Scheduled maintenance until 6:00 AM EST.
Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)
ID: PAR-24-106Type: BOTH
Overview

Topic

Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: SBIRPhase: BOTHYear: 2024
Timeline
  1. 1
    Release Jan 9, 2024 12:00 AM
  2. 2
    Open Apr 30, 2024 12:00 AM
  3. 3
    Next Submission Due May 30, 2024 12:00 AM
  4. 4
    Close May 31, 2024 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for solutions to enable regional clinician-to-clinician genomic medicine eConsult services. The purpose of this funding opportunity is to develop products or technologies that will support the development and sustainment of eConsult services in the field of genomic medicine. Small businesses can submit Small Business Innovation Research (SBIR) Phase I, Direct to Phase II, and Fast-Track grant applications. The objective of SBIR and STTR Phase I is to establish the technical merit and feasibility of the proposed research, while Phase II aims to advance the technology towards commercialization. The funding opportunity is open until May 31, 2024, and interested applicants can find more information on the grants.gov website. The specific objectives of this funding opportunity include addressing barriers to setting up eConsult services, conducting outreach and education, and providing eConsults. Solutions of interest include technologies for transmitting and managing eConsult requests, artificial intelligence or machine learning solutions for triaging and creating responses, and services or products for managing the administration and education of eConsult services. The ultimate goal is to reduce costs, time, and increase access to regional genomic medicine eConsult services.

Files
No associated files provided.
Similar Opportunities
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and eliminate health disparities. The research should focus on identifying and addressing issues within clinical diagnostics that perpetuate health inequity. The projects may involve existing clinical diagnostics or propose new ones. Applicants are encouraged to consider social determinants of health during the development process and include input from relevant populations that experience health disparities. The funding opportunity accepts different types of projects, including those that address pigment variation in imaging devices, utilize equitable parameters instead of non-biological parameters like race, improve analytics or bioinformatics, develop clinical decision support tools, validate new technology, or further develop existing technology. The funding is available through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding options. The open date for applications is March 5, 2024, and the close date is January 6, 2027. For more information, including specific research objectives and areas of interest, interested parties can visit the solicitation agency URL provided.
Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed) - https://grants.nih.gov/grants/guide/PA-files/PAR-24-158.html
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics through their Small Business Innovation Research (SBIR) program. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that address health disparities created by clinical laboratory assays and point-of-care devices that fail to incorporate diverse patient groups. The goal is to develop clinical diagnostics that are accessible to populations that experience health disparities and to eliminate health inequities. The research objectives include developing clinical diagnostics that meet or exceed the quality of existing diagnostics, considering social determinants of health during the development process, and including input from relevant populations that experience health disparities. The funding opportunity accepts various types of projects, such as novel technologies addressing known issues in existing diagnostics, projects addressing health inequities in analytics or bioinformatics, and pilot or small-scale projects validating new technology. The funding is available for both Phase I and Phase II projects, with the option for a Fast Track application. The National Institute of Arthritis and Musculoskeletal and Skin Diseases, the Sexual & Gender Minority Research Office, and the National Human Genome Research Institute are also participating in this funding opportunity.
Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for addressing health inequities in clinical diagnostics. The purpose of this funding opportunity is to encourage small businesses to develop improved or alternative clinical diagnostics that incorporate diverse patient groups and address health disparities. The goal is to lay the groundwork for more equitable clinical diagnostics that lead to improved health, healthcare delivery, and the elimination of health disparities. The research objectives include developing clinical diagnostics that are accessible to populations that experience health disparities, considering social determinants of health during the development process, and including input from relevant populations. The funding opportunity accepts various types of projects, such as novel technologies, analytics or bioinformatics, clinical decision support tools, and pilot or small-scale projects. The funding is available through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding options. The open date for applications is March 5, 2024, and the close date is January 6, 2027. More information can be found on the grants.gov website.
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).